Pharsight

NEKTAR THERAPEUTICS patents facing oppositions

Top patents of NEKTAR THERAPEUTICS facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3134123B1 17 Feb, 2021 Il-2rbeta-selective agonists in combination with an anti-ctla-4 antibody or an an anti-pd-1 antibody Feb, 2035 1
EP2453962B1 14 Mar, 2018 Negatively biased sealed nebulizers systems and methods Jul, 2030 1
EP3094331B1 27 Dec, 2017 Combination-based treatment method Jan, 2035 1